Tenaya Therapeutics, Inc.
TNYA
$0.73
-$0.01-1.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.46% | -15.71% | 0.22% | -12.39% | -17.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.61% | -26.32% | -15.73% | -21.62% | -21.87% |
| Operating Income | 13.22% | 27.14% | 15.73% | 21.62% | 21.87% |
| Income Before Tax | -86.37% | 28.26% | 15.36% | 20.91% | 20.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -86.37% | 28.26% | 15.36% | 20.91% | 20.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.37% | 28.26% | 15.36% | 20.91% | 20.89% |
| EBIT | 13.22% | 27.14% | 15.73% | 21.62% | 21.87% |
| EBITDA | 12.71% | 26.43% | 16.02% | 22.50% | 23.35% |
| EPS Basic | -39.44% | 63.64% | 58.21% | 58.29% | 58.36% |
| Normalized Basic EPS | 30.65% | 63.68% | 58.24% | 58.26% | 58.34% |
| EPS Diluted | -39.44% | 63.64% | 58.21% | 58.29% | 58.36% |
| Normalized Diluted EPS | 30.65% | 63.68% | 58.24% | 58.26% | 58.34% |
| Average Basic Shares Outstanding | 33.65% | 97.40% | 102.59% | 89.58% | 89.94% |
| Average Diluted Shares Outstanding | 33.65% | 97.40% | 102.59% | 89.58% | 89.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |